Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until September 1, 2024 - Podcast Online CME Education

Hailey Thompson, PharmD shares SHOCKing updates on the use of corticosteroids in septic shock.

Available until July 31, 2024 - Online CME Course

In this one-hour no-cost Grand Rounds session from Mayo Clinic Healthcare in London, our experts discuss advances in the evolving field of regenerative medicine, rooted in restoring form and function, an exciting component of modern health care. Regenerative medicine harnesses breakthroughs in technologies to address major unmet needs of the population, both nationally and globally. Built on enduring institutional values, regenerative medicine at Mayo Clinic represents the intersection of Research, Practice, and Education. New research on the use of extracellular vesicles, or exosomes, could be useful for skin tissue restitution in intractable

October 11 - December 12, 2023

This course is only available to Mayo Clinic Personnel

This course will only be offered via livestream.

Mayo Clinic Project ECHO™ (Extension for Community Healthcare Outcomes) seeks to be a force multiplier to share academic clinical knowledge with health care providers who practice in rural and underserved areas and want to increase their knowledge of how to identify and treat liver disease. During regularly scheduled ECHO sessions, via Zoom, participants will learn to assess and risk-stratify patients to identify liver disease. Interactive didactics will be presented in the context of “All Teach. All Learn.” CME credit will be awarded to participants, at no cost. Through the ECHO model, local providers are trained by academic specialists. As a result of this training higher quality healthcare will be delivered locally, disease progression is arrested, steps are made toward health equity in marginalized demographics, and population health outcomes are improved. The aim of Mayo Clinic Project ECHO is to effectively improve the capacity of clinicians treating liver disease throughout Mayo Clinic Health System to improve patient outcomes. The project is a collaborative model of medical education and care management that helps providers deliver care to patients with chronic liver disease. The project strives to narrow gaps in healthcare disparities for unrepresented minority populations and reduce the burden on the patients by allowing improved access to specialty care. Why is ECHO Important? Prevalence of Liver Disease Liver disease is a significant health concern that is often silent. It is estimated that 35% of the US population suffers from silent liver disease. Liver disease encompasses a range of conditions that affect the liver’s function and structure, including steatotic liver disease (previously known as fatty liver), alcoholic liver disease, viral hepatitis, cirrhosis, liver cancer, and more. If liver disease is diagnosed and addressed early, the consequences can be mitigated, and patient outcomes are much improved.

Available until December 31, 2025 - Online CME Course

The Medical Breast Training Program will provide clinicians tools and knowledge to evaluate and manage common breast complaints, to perform personalized risk assessment and risk management and to care for breast cancer survivors. The goal is to educate practitioners in the field about guidelines for screening and diagnosis, risk reduction, genetics, and survivorship.  The Advanced Topics curriculum goes beyond the basics of screening and diagnosis to help providers confidently identify and manage those at risk and effectively care for survivors. Topics include benign and malignant breast lesions; bone health; sexuality; integrative medicine; hormones; legal issues; and much more. The course incorporates both pre-recorded lectures and interactive case discussion sessions.

Available until September 1, 2024 - Podcast Online CME Education

Kelli Herrin, PharmD reviews the pathophysiology of transthyretin amyloidosis cardiomyopathy and provides updates on medication options.